1 May 2016

Sheeran shines on Romanian trials

James Crux

Brian Sheeran, chairman of green technology company Virotec, delivered some good news to investors today with exciting news of trials in Romania of its Bauxsol waste water cleaning technology.

Sheeran and Dr David McConchie, a fellow director and the group's chief scientific consultant, had just visited Baia Mare in Romania, joining other Virotec staff who were treating 3 million litres of Acid Mine Drainage (AMD) with the group's Bauxsol technology. 'We've had large enquiry levels from Europe', said Sheeran, 'and were invited to Baia Mare by Romanian mining company Remin to do trials'.

Formerly a mining venture Down Under, Virotec (VTI) has worldwide marketing and distribution rights to 'Bauxsol', a 'green' technology that neutralises acid and removes heavy metals from environmentally contaminated water. Although the actual results have not been released yet, McConchie hinted at positive news. 'The initial trials gave fantastic results', he added. 'Our aim at Virotec is not only to protect the environment but to do it in an economically appealing way that will save mining companies money'.

All of this should have impressed observers from the United Nations Environment Programme, the European Union in Brussels and the London Stock Exchange who attended the Romanian trials. Significantly, the pair also boasted that the United States EPA is also currently trialling the technology. 'Trials in the US should be completed by December and we're hopeful of gaining EPA approval for the product for America', said Sheeran.

Virotec, already quoted on the Australian Stock Exchange, listed on Aim in July following a placing of 27.5 million new shares at 14p raising £3.36 million net. 'We came to Aim to internationalise the technology and be first to market', explained Sheeran. W H Ireland was broker to the float.

Today the shares were unchanged at 12.25p.

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Seeking Inspiration in neonatal care 

Inspiration Healthcare (AIM: IHC) has turned the usual development pattern for small medical technology companies on its head. Unlike typical small companies in the sector, it's already profitable with a cash generative distibution arm. It's aim now is to start pushing its own products through that pipeline.

GB going great guns

GB Group (AIM: GBG) has released a positive update on trading for the year to March. Operating profits are comfortably ahead of expectations and show 24 per cent growth. What’s slightly unsettling, especially given the demanding prospective p/e ratio of 30, is the news that long-time CEO Richard Law is to step down.

Looking after the talent

NetDimensions (AIM: NETD) shares enjoyed a strong recovery in the years following the financial crisis, only to run out of steam last summer. The subsequent 40 per cent fall in the share price looks like it’s now played out, with the stock responding well to recent results.

The Tide is rising

Crimson Tide (AIM: TIDE) is a tiny tech company with only £1.4 million sales just reported for the 2015 year. However it’s highly unusual for its size in that it’s profitable and generates cash. Sales are forecast to grow to £2.4 million next year and if this momentum can be built on, the shares could get interesting.

Mi-Pay moving the right way

Mi-Pay (AIM: MPAY) has announced results which show reduced losses and evidence that things are moving in the right direction. The company provides payment services for mobiles; so it’s certainly exposed to a growing markets. Costs and cash outflows have been reduced, while the value of customer transactions grew by 31 per cent in 2015.

Cropper beats expectations

Specialist paper maker James Cropper (AIM: CRPR) has pleased the market with an upbeat end-of-year trading statement. After a good run the shares had spent a few months consolidating; but today’s news has seen them move up 15 per cent and into new all-time high territory.

More News